Outcomes related to the disease and the use of 3D-based external beam radiation and image-guided brachytherapy

Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management

Volumn , Issue , 2011, Pages 263-282

  Sturdza, Alina ^a   Pötter, Richard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855991923     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-68958-4_25     Document Type: Chapter

References (37)

1. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol. 2008; 86(2): 142-7.
2. Beriwal S, Gan GN, et al. Early clinical outcome with concurrent chemotherapy and extended-feld, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2007; 68(1): 166-71.
3. Chargari C, Magne N, et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2008; 74: 133-9.
4. Charra-Brunaud C. Preliminary results of a French prospective multicentric study of 3D pulsed dose-rate brachytherapy for cervix carcinoma. Cancer Radiothér. 2008; 12(6-7): 527-31.
5. Cozzi L, Dinshaw KA, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fxed feld IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008; 89(2): 180-91.
6. DeBrabandere M et al. Potential of dose optimisation in MRI based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2008; 88(2): 217-26.
7. Dimopoulos J, Schmid M Treatment of locally advanced vaginal cancer with radio-chemotherapy and MRI-guided brachytherapy: clinical feasibility and frst results Brachytherapy. 2009;
8. Dimopoulos J, Lang S, et al. Dose-volume histogram parameters and local tumor control in MR image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009; 75(1): 56-63.
9. Dimopoulos J, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol. 2009; 93(2): 311-5.
10. Eifel PJ, Jhingran A, et al. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006; 16(3): 1106-11.
11. Erickson B, Albano K, et al. CT-guided interstitial implantation of gynecologic malignancies. Int J Radiat Oncol Biol Phys. 1996; 36(3): 699-709.
12. Georg P et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol. 2009; 91(2): 173-80.
13. Gerbaulet A, Potter R, et al. Cervix cancer. In: Gerbaulet A, editor. GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002. p. 301-63.
14. Gerbaulet A, Pötter R, et al. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002.
15. Gerstner N, Wachter S, et al. The beneft of Beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol. 1999; 51(1): 71-8.
16. Grigsby PW. Role of PET in gynecologic malignancy. Curr Opin Oncol. 2009; 21(5): 420-4.
17. Haie-Meder C. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Radiother Oncol. 2009; 93(2): 316-21.
18. Haie-Meder C., Potter R, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005; 74(3): 235-45.
19. Kirisits C, Potter R, et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005; 62(3): 901-11.
20. Knocke TH. Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys. 1997; 37(2): 359-65.
21. Lang S, Kirisits C, et al. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys. 2007; 69(2): 619-27.
22. Lang S, Nulens A, et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol. 2006; 78(2): 185-93.
23. Lindegaard JC, Tanderup K, et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008; 71(3): 756-64.
24. Nag S, Erickson B, et al. The American Brachytherapy Society recommendations for highdose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000; 48(1): 201-11.
25. Narayan K, Fisher R. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009; 19(5): 912-8.
26. Narayan K, van Dyk S. Comparative study of LDR (mancester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications and survival. Int J Radiat Oncol Biol Phys. 2009; 74(5): 1529-35.
27. Potter R. Modern imaging in brachytherapy. In: Gerbaulet A, Potter R, Mazeron JJ, Meertens H, Van LE. The GEC ESTRO handbook of brachytherapy. 2002; p. 123-151.
28. Potter R, Dimopoulos J, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007; 83(2): 148-55.
29. Potter R, Haie-Meder C, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006; 78(1): 67-77.
30. Potter R, Kirisits C, et al. Present status and future of high-precision image-guided adaptive brachytherapy for cervix carcinoma. Acta Oncol. 2008; 47(7): 1325-36.
31. Potter R, Knocke TH, et al. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiothér. 2000; 4(2): 159-72.
32. Tan LT, Coles CE, et al. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. Clin Oncol (R Coll Radiol). 2009; 21(3): 175-82.
33. Van Dyk S., Narayan K, et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys. 2009; 75(1): 64-70.
34. Viswanathan AN, Cormack R, et al. MR-guided interstitial brachytherapy for recurrent endo-metrial cancer. Int J Radiat Oncol Biol Phys. 2006; 66(1): 91-9.
35. Viswanathan AN, Racine ML, et al. Final results of a prospective study of MR-based interstitial gynecologic brachytherapy. Brachytherapy. 2008; 7(2): 148.
36. Weitmann HD, Knocke TH, et al. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlenther Onkol. 2006; 182(2): 86-95.
37. Weitmann HD, Potter R, et al. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modifed Heyman packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2005; 62(2): 468-78.